ArticleAdvances in therapy2024

Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome.

Raymond C Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.